The ROE as of November 2024 (TTM) for TFF Pharmaceuticals, Inc. (TFFP) is -310.17%

According to TFF Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current ROE is -310.17%. This represents a change of 257.43% compared to the average of -86.78% of the last 4 quarters.

TFF Pharmaceuticals, Inc. (TFFP) Historical ROE (quarterly & annually)

How has TFFP ROE performed in the past?

The mean historical ROE of TFF Pharmaceuticals, Inc. over the last ten years is 1.15%. The current -310.17% ROE has changed -127.06% with respect to the historical average. Over the past ten years (40 quarters), TFFP's ROE was at its highest in in the September 2018 quarter at 0%. The ROE was at its lowest in in the September 2024 quarter at -113.00%.

TFF Pharmaceuticals, Inc. (TFFP) ROE by Quarter and Year

Discovering the peaks and valleys of TFF Pharmaceuticals, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

TFF Pharmaceuticals, Inc. (TFFP) Average ROE

How has TFFP ROE performed in the past?

The current ROE of TFF Pharmaceuticals, Inc. (TFFP) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

TFF Pharmaceuticals, Inc. (TFFP) ROE vs. Peers

How is TFFP’s ROE compared to its peers?

TFF Pharmaceuticals, Inc.’s ROE is greater than Gain Therapeutics, Inc. (-203.91%), greater than aTyr Pharma, Inc. (-56.83%), greater than IN8bio, Inc. (-197.15%), greater than Lantern Pharma Inc. (-56.90%), greater than INmune Bio, Inc. (-115.51%), greater than Anebulo Pharmaceuticals, Inc. (-184.40%), less than Abcam plc (-1.23%), greater than AN2 Therapeutics, Inc. (-57.63%), greater than Anixa Biosciences, Inc. (-52.41%), greater than Immunome, Inc. (-139.72%), less than Annovis Bio, Inc. (874.76%), greater than Cognition Therapeutics, Inc. (-150.93%), greater than TScan Therapeutics, Inc. (-58.72%), greater than Cue Biopharma, Inc. (-156.38%), greater than Dermata Therapeutics, Inc. (-247.40%), greater than Oncorus, Inc. (-82.19%), less than Orgenesis Inc. (199.52%), greater than Quoin Pharmaceuticals, Ltd. (-126.19%), less than Apexigen, Inc. (48.27%),

Build a custom stock screener for TFF Pharmaceuticals, Inc. (TFFP) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like TFF Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

TFF Pharmaceuticals, Inc. (TFFP) and other stocks custom spreadsheet templates

The easiest way to analyze a company like TFF Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.